CAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will present at two upcoming investor conferences.
- 2023 Wells Fargo Healthcare Conference: Fireside chat on Thursday, September 7, 2023, at 11:00 a.m. ET in Boston, MA.
- Morgan Stanley Global Healthcare Conference: Fireside chat on Monday, September 11, 2023, at 11:20 a.m. ET in New York, NY.
Live audio webcasts of the Wells Fargo ...